Preclinical Evaluation of the Oncolytic Vaccinia Virus TG6002 by Translational Research on Canine Breast Cancer

Oncolytic virotherapy is a promising therapeutic approach for the treatment of cancer. TG6002 is a recombinant oncolytic vaccinia virus deleted in the thymidine kinase and ribonucleotide reductase genes and armed with the suicide gene FCU1, which encodes a bifunctional chimeric protein that efficien...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Mol Ther Oncolytics
Главные авторы: Béguin, Jérémy, Foloppe, Johann, Maurey, Christelle, Laloy, Eve, Hortelano, Julie, Nourtier, Virginie, Pichon, Christelle, Cochin, Sandrine, Cordier, Pascale, Huet, Hélène, Quemeneur, Eric, Klonjkowski, Bernard, Erbs, Philippe
Формат: Artigo
Язык:Inglês
Опубликовано: American Society of Gene & Cell Therapy 2020
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7533293/
https://ncbi.nlm.nih.gov/pubmed/33072863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2020.08.020
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы